Epstein-Barr virus-associated cancers
Two postdoctoral positions are immediately available to study the oncogenic mechanisms of Epstein-Barr virus (EBV). The ideal candidate should have a Ph.D in the field of virology or cancer biology. The projects will investigate EBV pathogenesis and mechanisms of genomic instability in nasopharyngeal carcinoma and pediatric samples. Opportunities also exist to work with mice. Experience in DNA repair or tumor virology is preferred, but candidates with independent thinking, experimental rigor and evidence of scientific writing and presentation will be the most highly ranked.
Current projects in the Shair lab include: 1) oncogenic signaling mechanisms of EBV latent membrane proteins (LMP) 1 and LMP2A, 2) determinants of EBV latency and persistence, and 3) mouse models of EBV-associated cancers. The Shair lab at the University of Pittsburgh is housed in the Cancer Virology Program, Hillman Cancer Center, where our common interest is to elucidate the molecular basis of cancer and translational medicine.
To be considered, please submit a C.V. and names of 3 references to Dr. Shair (firstname.lastname@example.org). Applicants will be continually reviewed until the position is filled.